| Dr Joel A Di Santi, DPM | |
|
2699 Seville Blvd Unit 402, Clearwater, FL 33764-1144 | |
| (724) 493-3250 | |
| Not Available |
| Full Name | Dr Joel A Di Santi |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 35 Years |
| Location | 2699 Seville Blvd Unit 402, Clearwater, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124099478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | PO2045 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albuquerque Indian Health Center | 7719883164 | 46 |
| Pueblo Of Isleta | 9739080631 | 8 |
News Archive
Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
In a new study from Lawson Health Research Institute and Western University, researchers partnered with youth receiving care at the First Episode Mood and Anxiety Program at London Health Sciences Centre to better understand personal perspectives on care and treatment outcomes.
New human research suggests the chemical oxytocin dubbed the "cuddle hormone" because of its importance in bonding between romantic partners and mothers and children also influences feelings of well-being and sensitivity to advertising.
A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.
› Verified 9 days ago
| Provider Name | Dhhs,phs,naihs, Gallup Indian Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225002322 PECOS PAC ID: 3173436409 Enrollment ID: O20031111000840 |
News Archive
Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
In a new study from Lawson Health Research Institute and Western University, researchers partnered with youth receiving care at the First Episode Mood and Anxiety Program at London Health Sciences Centre to better understand personal perspectives on care and treatment outcomes.
New human research suggests the chemical oxytocin dubbed the "cuddle hormone" because of its importance in bonding between romantic partners and mothers and children also influences feelings of well-being and sensitivity to advertising.
A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.
› Verified 9 days ago
| Provider Name | Santa Ana Health Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649331323 PECOS PAC ID: 4880590298 Enrollment ID: O20031208000817 |
News Archive
Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
In a new study from Lawson Health Research Institute and Western University, researchers partnered with youth receiving care at the First Episode Mood and Anxiety Program at London Health Sciences Centre to better understand personal perspectives on care and treatment outcomes.
New human research suggests the chemical oxytocin dubbed the "cuddle hormone" because of its importance in bonding between romantic partners and mothers and children also influences feelings of well-being and sensitivity to advertising.
A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.
› Verified 9 days ago
| Provider Name | Albuquerque Indian Health Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659458917 PECOS PAC ID: 7719883164 Enrollment ID: O20031208001026 |
News Archive
Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
In a new study from Lawson Health Research Institute and Western University, researchers partnered with youth receiving care at the First Episode Mood and Anxiety Program at London Health Sciences Centre to better understand personal perspectives on care and treatment outcomes.
New human research suggests the chemical oxytocin dubbed the "cuddle hormone" because of its importance in bonding between romantic partners and mothers and children also influences feelings of well-being and sensitivity to advertising.
A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.
› Verified 9 days ago
| Provider Name | Zia Health Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831250398 PECOS PAC ID: 4789652488 Enrollment ID: O20040921000441 |
News Archive
Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
In a new study from Lawson Health Research Institute and Western University, researchers partnered with youth receiving care at the First Episode Mood and Anxiety Program at London Health Sciences Centre to better understand personal perspectives on care and treatment outcomes.
New human research suggests the chemical oxytocin dubbed the "cuddle hormone" because of its importance in bonding between romantic partners and mothers and children also influences feelings of well-being and sensitivity to advertising.
A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel A Di Santi, DPM 2699 Seville Blvd Unit 402, Clearwater, FL 33764-1144 Ph: (724) 493-3250 | Dr Joel A Di Santi, DPM 2699 Seville Blvd Unit 402, Clearwater, FL 33764-1144 Ph: (724) 493-3250 |
News Archive
Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
In a new study from Lawson Health Research Institute and Western University, researchers partnered with youth receiving care at the First Episode Mood and Anxiety Program at London Health Sciences Centre to better understand personal perspectives on care and treatment outcomes.
New human research suggests the chemical oxytocin dubbed the "cuddle hormone" because of its importance in bonding between romantic partners and mothers and children also influences feelings of well-being and sensitivity to advertising.
A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.
› Verified 9 days ago
Podiatry Associates Of Florida, Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4625 E Bay Dr Ste 106, Clearwater, FL 33764 Phone: 904-251-5053 Fax: 904-224-2002 | |
Bruce J Levine, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2521 Countryside Blvd, Clearwater, FL 33763 Phone: 727-797-5008 Fax: 797-791-1330 | |
Jacqueline Claudia Lucke, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 2521 Countryside Blvd, Clearwater, FL 33763 Phone: 727-797-5008 | |
Naomi S Marsh, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2451 N Mcmullen Booth Rd, Ste 206, Clearwater, FL 33759 Phone: 813-960-2888 Fax: 813-925-1435 | |
Dr. Christine P Miller, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13600 Icot Blvd Bldg B, Clearwater, FL 33760 Phone: 888-290-6321 Fax: 727-669-8417 | |
John Savidakis Jr.,p.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 2701 Park Dr, Suite 6, Clearwater, FL 33763 Phone: 727-796-1490 Fax: 727-797-5611 | |
Dr. Matthew Dean Westerfield, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 13600 Icot Blvd, Bldg B, Clearwater, FL 33760 Phone: 888-290-6321 Fax: 888-875-1592 |